Functionalized carriers for the improved delivery of plasminogen activators

International Journal of Pharmaceutics

Volumn 424, Issue 1-2, 2012, Pages 1-11

  Vaidya, Bhuvaneshwar ^a   Agrawal, G P ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Novel drug delivery systems; Plasminogen activators; Targeting; Thrombolytic agents

Indexed keywords

ANISTREPLASE; DRUG CARRIER; FIBRIN; FIBRIN ANTIBODY; LIPOSOME; NANOCARRIER; PLASMINOGEN ACTIVATOR; POLYMER; STAPHYLOKINASE; THROMBOCYTE ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR;

AREA UNDER THE CURVE; BLEEDING; BLOOD CLOT LYSIS; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; HUMAN; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; THROMBOSIS; THROMBUS; ULTRASOUND;

ANIMALS; DRUG DELIVERY SYSTEMS; FIBRINOLYTIC AGENTS; HUMANS; PLASMINOGEN ACTIVATORS;

EID: 84856976934     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.12.032     Document Type: Review

References (93)

1. A. Alonso, C.E. Dempfle, A.D. Martina, M. Stroick, M. Fatar, K. Zohsel, E. Allémann, M.G. Hennerici, and S. Meairs In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound Thrombosis Res. 124 2009 70 74
2. J. Alter, C.A. Sennoga, D.M. Lopes, R.J. Eckersley, and D.J. Wells Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer Ultrasound Med. Biol. 35 2009 976 984
3. S.H. Baek, S.J. Park, S.E. Jin, J.K. Kim, C.K. Kim, and J.M. Hwang Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits Eur. J. Pharm. Biopharm. 72 2009 546 551
4. A. Banerjee, Y. Chisti, and U.C. Banerjee Streptokinase - a clinically useful thrombolytic agent research review paper Biotechnol. Adv. 22 2004 287 307 (Pubitemid 38024782)
5. D.B. Baruah, R.N. Dash, M.R. Chaudhari, and S.S. Kadam Plasminogen activators: a comparison Vasc. Pharmacol. 44 2006 1 9 (Pubitemid 41799584)
6. C.O. Beauchamp, S.L. Gonias, D.P. Menapace, and S.V. Pizzo A new procedure for the synthesis of polyethylene glycolprotein adducts: effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and a2-macroglobulin Anal. Biochem. 131 1983 25 33 (Pubitemid 13058974)
7. F. Bi, J. Zhang, Y. Su, Y.C. Tang, and J.N. Liu Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis Biomaterials 30 2009 5125 5130
8. C. Bode, G. Meinhardt, M.S. Runge, M. Freitag, T. Nordt, M. Arens, J.B. Newell, W. Kubler, and E. Haber Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation Circulation 84 1991 805 813
9. R. Carnemolla, V.V. Shuvaev, and V.R. Muzykantov Targeting antioxidant and antithrombotic biotherapeutics to endothelium Semin. Thromb. Hemost. 36 2010 332 342
10. F. Chiellini, A.M. Piras, M. Gazzarri, C. Bartoli, M. Ferri, L. Paolini, and E. Chiellini Bioactive polymeric materials for targeted administration of active agents: synthesis and evaluation Macromol. Biosci. 8 2008 516 525
11. T.W. Chung, S.S. Wang, and W.J. Tsai Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co- glycolide) (PLGA) nanoparticles Biomaterials 29 2008 228 237
12. D. Collen, D.C. Stump, and H.K. Gold Thrombolytic therapy Ann. Rev. Med. 39 1988 405 423 (Pubitemid 19090811)
13. W.C. Culp, and T.C. McCowan Ultrasound augmented thrombolysis Curr. Med. Imaging Rev. 1 2005 5 12
14. K. Danielyan, K. Ganguly, B.S. Ding, D. Atochin, S. Zaitsev, J.C. Murciano, P.L. Huang, S.E. Kasner, D.B. Cines, and V.R. Muzykantov Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator Circulation 118 2008 1442 1449
15. S.F. De Meyer, K. Vanhoorelbeke, K. Broos, I.I. Salles, and H. Deckmyn Antiplatelet drugs Br. J. Haematol. 142 2008 515 528 (Pubitemid 352020216)
16. M. Dewerchin, and D. Collen Enhancement of the thrombolytic potency of plasminogen activators by conjugation with clot-specific monoclonal antibodies Bioconjug. Chem. 2 1991 293 300
17. P.A. Dijkmans, L.J.M. Juffermans, R.J.P. Musters, A. van Wamel, F.J. ten Cate, W. van Gilst, C.A. Visser, N. de Jong, and O. Kamp Microbubbles and ultrasound: from diagnosis to therapy Eur. J. Echocardiogr. 5 2004 245 256 (Pubitemid 38950150)
18. B.S. Ding, C. Gottstein, A. Grunow, A. Kuo, K. Ganguly, S.M. Albelda, D.B. Cines, and V.R. Muzykantov Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature Blood 106 2005 4191 4198 (Pubitemid 41775926)
19. B.S. Ding, N. Hong, J.C. Murciano, K. Ganguly, C. Gottstein, M. Christofidou-Solomidou, S.M. Albelda, A.B. Fisher, D.B. Cines, and V.R. Muzykantov Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature Blood 111 2008 1999 2006 (Pubitemid 351451510)
20. T.A. Elbayoumi, and V.P. Torchilin Liposomes for targeted delivery of antithrombotic drugs Exp. Opin. Drug Deliv. 5 2008 1185 1198
21. S. Erdogan, A.Y. Özer Dr.; B. Volkan, B. Caner, and H. Bilgili Thrombus localization by using streptokinase containing vesicular systems Drug Deliv. 13 2006 303 309 (Pubitemid 43739142)
22. E.C. Everbach, and C.W. Francis Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz Ultrasound Med. Biol. 26 2000 1153 1160
23. C.W. Francis Ultrasound-enhanced thrombolysis Echocardiography 18 2001 239 246 (Pubitemid 32406048)
24. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (2) N Engl. J. Med. 326 1992 310 318
25. K. Ganguly, T. Krasik, S. Medinilla, K. Bdeir, D.B. Cines, V.R. Muzykantov, and J.C. Murciano Blood clearance and activity of erythrocytecoupled fibrinolytics J. Pharmacol. Exp. Ther. 312 2005 1106 1113 (Pubitemid 40293770)
26. R.B. Greenwald, Y.H. Choe, J. McGuire, and C.D. Conover Effective drug delivery by PEGylated drug conjugates Adv. Drug Deliv. Rev. 55 2003 217 250 (Pubitemid 36135917)
27. A.S. Gupta, G. Huang, B.J. Lestini, S. Sagnella, K. Kottke-Marchant, and R.E. Marchant RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system Thromb. Haemost. 93 2005 106 114 (Pubitemid 40124263)
28. J.M. Harris, and R.B. Chess Effect of pegylation on pharmaceuticals Nat. Rev. Drug Discov. 2 2003 214 221 (Pubitemid 37361666)
29. J.L. Heeremans, H.R. Gerritsen, S.P. Meusen, F.W. Mijnheer, R.S. Gangaram Panday, R. Prevost, C. Kluft, and D.J. Crommelin The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage J. Drug Target. 3 1995 301 310 (Pubitemid 26032032)
30. J.L. Heeremans, R. Prevost, M.E. Bekkers, P. Los, J.J. Emeis, C. Kluft, and D.J. Crommelin Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA Thromb. Haemost. 73 1995 488 494
31. S. Hernot, and A.L. Klibanov Microbubbles in ultrasound-triggered drug and gene delivery Adv. Drug Deliv. Rev. 60 2008 1153 1166
32. B. Holt, and A.S. Gupta Streptokinase loading in liposomes for vascular targeted nanomedicine applications: encapsulation efficiency and effects of processing J. Biomater. Appl. 2010 10.1177/0885328210374778
33. G. Huang, Z. Zhou, R. Srinivasan, M.S. Penn, K. Kottke-Marchant, R.E. Marchant, and A.S. Gupta Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets Biomaterials 29 2008 1676 1685
34. M.D. Kaminski, Y. Xie, C.J. Mertz, M.R. Finck, H. Chen, and A.J. Rosengart Encapsulation and release of plasminogen activator from biodegradable magnetic microcarriers Eur. J. Pharm. Sci. 35 2008 96 103
35. I.S. Kim, H.G. Choi, H.S. Choi, B.K. Kim, and C.K. Kim Prolonged systemic delivery of streptokinase using liposome Arch. Pharm. Res. 21 1998 248 252
36. J.Y. Kim, J.K. Kim, J.S. Park, Y. Byun, and C.K. Kim The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator Biomaterials 30 2009 5751 5756
37. M.E. Klegerman, Y. Zou, and D.D. Mcpherson Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator J. Liposome Res. 2008 95 112 (Pubitemid 351874104)
38. Y. Kodera, A. Matsushima, M. Hiroto, H. Nishimura, A. Ishii, T. Ueno, and Y. Inada Pegylation of proteins and bioactive substances for medical and technical applications Prog. Polym. Sci. 23 1998 1233 1271 (Pubitemid 128676291)
39. A. Koide, S. Suzuki, and S. Kobayashi Preparation of polyethylene glycol-modified streptokinase with disappearance of binding ability towards anti-serum and retention of activity FEBS Lett. 143 1982 73 76 (Pubitemid 12057990)
40. A. Kunamneni, T.T.A. Abdelghani, and P. Ellaiah Streptokinase - the drug of choice for thrombolytic therapy J. Thromb. Thrombolysis 23 2007 9 23
41. H.F. Langer, and M. Gawaz Platelet-vessel wall interactions in atherosclerotic disease Thromb. Haemost. 99 2008 480 486 (Pubitemid 351549284)
42. J.K. Leach, E.A. O'Rear, E. Patterson, Y. Miao, and A.E. Johnson Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase Thromb. Haemost. 90 2003 64 70 (Pubitemid 36873860)
43. J.K. Leach, E. Patterson, and E.A. O'Rear Distributed intraclot thrombolysis: mechanism of accelerated thrombolysis with encapsulated plasminogen activators J. Thromb. Haemost. 2 2004 1548 1555 (Pubitemid 40186169)
44. B.J. Lestini, S.M. Sagnella, Z. Xu, M.S. Shive, N.J. Richter, J. Jayaseharan, A.J. Case, K. Kottke-Marchant, J.M. Anderson, and R.E. Marchant Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery J. Control. Release 78 2002 235 247 (Pubitemid 34081868)
45. T. Li, K. Tachibana, M. Kuroki, and M. Kuroki Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice - initial results Radiology 229 2003 423 428 (Pubitemid 37310829)
46. H.R. Lijnen, and D. Collen Development of thrombolytic agents Biotechnol. Adv. 11 1993 115 130 (Pubitemid 23639936)
47. Q.L. Lu, H.D. Liang, T. Partridge, and M.J. Blomley Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage Gene Ther. 10 2003 396 405 (Pubitemid 36372447)
48. Y.H. Ma, Y.W. Hsu, Y.J. Chang, M.Y. Hua, J.P. Chen, and T. Wu Intra-arterial application of magnetic nanoparticles for targeted thrombolytic therapy: a rat embolic model J. Magn. Magn. Mater. 311 2007 342 346 (Pubitemid 46401028)
49. A.V. Maksimenko, and E.G. Tischenko New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate J. Thromb. Thrombolysis 7 1999 307 312 (Pubitemid 29322540)
50. D. Martina, E. Allemann, T. Bettinger, P. Bussat, A. Lassus, S. Pochon, and M. Schneider Grafting of abciximab to a microbubble-based ultrasound contrast agent for targeting to platelets expressing GP IIb/IIIa - characterization and in vitro testing Eur. J. Pharm. Biopharm. 68 2008 555 564 (Pubitemid 351318198)
51. O. Matsuo An ideal thrombolytic and antithrombotic agent J. Thromb. Haemost 3 2005 2154 2155
52. C.R. Mayer, and R. Bekeredjian Ultrasonic gene and drug delivery to the cardiovascular system Adv. Drug Deliv. Rev. 60 2008 1177 1192
53. M. McGuire, and P.P. Dobesh Therapeutic update on the prevention and treatment of venous thromboembolism J. Pharmacy Pract. 17 2004 289
54. Y. Mu, L. Li, and G. Ayoufu Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS Ultrasonics 49 2009 676 681
55. J.C. Murciano, A.A.R. Higazi, D.B. Cines, and V.R. Muzykantov Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile J. Control. Release 139 2009 190 196
56. J.C. Murciano, S. Medinilla, D. Eslin, E. Atochina, D.B. Cines, and V.R. Muzykantov Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes Nat. Biotechnol. 21 2003 891 896 (Pubitemid 36936194)
57. J.C. Murciano, S. Muro, L. Koniaris, M. Christofidou-Solomidou, D.W. Harshaw, S.M. Albelda, D.N. Granger, D.B. Cines, and V.R. Muzykantov ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface Blood 101 2003 3977 3984 (Pubitemid 36857875)
58. V.R. Muzykantov, D.V. Sakharov, M.D. Smirnov, G.P. Samokhin, and V.N. Smirnov Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot Biochim. Biophys. Acta 884 1986 355 362 (Pubitemid 17188780)
59. P.D. Nguyen, E.A. O'rear, A.E. Johnson, R. Lu, and B.M. Fung Thrombolysis using liposomal-encapsulated streptokinase: an in vitro study Proc. Soc. Exp. Biol. Med. 192 1989 261 269 (Pubitemid 20051480)
60. P.D. Nguyen, E.A. O'Rear, A.E. Johnson, E. Patterson, T.L. Whitsett, and R. Bhakta Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase Circ. Res. 66 1990 875 878 (Pubitemid 20086925)
61. N.M. Orekhova, R.S. Akchurin, A.A. Belyaev, M.D. Smirnov, S.E. Ragimov, and A.N. Orekhov Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells Thrombosis Res. 57 1990 611 616 (Pubitemid 20110426)
62. K. Ouriel A history of thrombolytic therapy J. Endovasc. Ther. 11 2004 128 133
63. A.M. Piras, F. Chiellini, C. Fiumi, C. Bartoli, E. Chiellini, B. Fiorentino, and C. Farina A new biocompatible nanoparticle delivery system for the release of fibrinolytic drugs Int. J. Pharm. 357 2008 260 271
64. D.F. Ranney, and H.H. Huffaker Magnetic microspheres for the targeted controlled release of drugs and diagnostic agents Ann. N.Y. Acad. Sci. 507 1987 104 119
65. Rivera-Bou, W.L.; Cabanas, J.G.; Villanueva, S.E.; 2010. Thrombolytic therapy. http://emedicine.medscape.com/article/811234-overview dated 07.06.2010.
66. M.S. Runge, C. Bode, G.R. Matsueda, and E. Habert Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo Proc. Natl. Acad. Sci. U.S.A. 84 1987 7659 7662
67. M.S. Runge, L.A. Harker, C. Bode, J. Ruef, A.B. Kelly, U.M. Marzec, E. Allen, R. Caban, S.Y. Shaw, E. Haber, and S.R. Hanson Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons Circulation 94 1996 1412 1422 (Pubitemid 26307274)
68. A. Scherpereel, J.J. Rome, R. Wiewrodt, S.C. Watkins, D.W. Harshaw, S. Alder, M. Christofidou-Solomidou, E. Haut, J.C. Murciano, M. Nakada, S.M. Albelda, and V.R. Muzykantov Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature J. Pharmacol. Exp. Ther. 300 2002 777 786 (Pubitemid 34164979)
69. G.J. Shaw, J.M. Meunier, S.L. Huang, C.J. Lindsell, D.D. McPherson, and C.K. Holland Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes Thromb. Res. 124 2009 306 310
70. ®, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre study Br. J. Radiol. 79 2006 44 51 (Pubitemid 43159315)
71. D.A.B. Smith, S.S. Vaidya, J.A. Kopechek, S.L. Huang, M.E. Klegerman, D.D. McPherson, and C.K. Holland Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes Ultrasound Med. Biol. 2010
72. J. Szemraj, B. Walkowiak, I. Kawecka, G. Janiszewska, W. Buczko, J. Bartkowiak, and E. Chabielska A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant I. In vitro study Thromb. Haemost. 3 2005 2156 2165 (Pubitemid 41727191)
73. K. Tachibana, and S. Tachibana The use of ultrasound for drug delivery Echocardiography 18 2001 323 328 (Pubitemid 32579095)
74. S.D. Tiukinhoy-Laing, S. Huang, M. Klegerman, C.K. Holland, and D.D. McPherson Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes Thrombosis Res. 119 2007 777 784 (Pubitemid 46441423)
75. S.D. Tiukinhoy-Laing Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes J. Drug Target 2007 109 114 (Pubitemid 46957696)
76. V.P. Torchilin, M.I. Papisov, N.M. Orekhova, A.A. Belyaev, A.D. Petrov, and S.E. Ragimov Magnetically driven thrombolytic preparation containing immobilized streptokinase-targeted transport and action Haemostasis 18 1988 113 116
77. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 2000 S81 S91
78. V.P. Torchilin Targeting of drugs and drug carriers within the cardiovascular system Adv. Drug Deliv. Rev. 17 1995 75 101
79. M.D. Torno, M.D. Kaminski, Y. Xie, R.E. Meyers, C.J. Mertz, X. Liu, O'Brien Jr.; and W.D.A.J. Rosengart Improvement of in vitro thrombolysis employing magnetically-guided microspheres Thrombosis Res. 121 2008 799 811 (Pubitemid 351492583)
80. G. Tsivgoulis, W.C. Culp, and A.V. Alexandrov Ultrasound enhanced thrombolysis in acute arterial ischemia Ultrasonics 48 2008 303 311
81. B. Vaidya, M.K. Nayak, D. Dash, G.P. Agrawal, and S.P. Vyas Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents Int. J. Pharm. 403 2011 254 261
82. F.M. Veronese Peptide and protein PEGylation: a review of problems and solutions Biomaterials 22 2001 405 417 (Pubitemid 32007845)
83. S.P. Vyas, and R.K. Khar Targeted and Controlled Drug Delivery Systems: Novel Carrier Systems 1st ed. 2002 CBS Publishers and Distributors New Delhi
84. S.P. Vyas, A. Singh, and V. Sihorkar Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting Crit. Rev. Ther. Drug Carrier Syst. 18 2001 1 76 (Pubitemid 32319397)
85. S.P. Vyas, and B. Vaidya Targeted delivery of thrombolytic agents: role of integrin receptors Exp. Opin. Drug Deliv. 6 2009 499 508
86. X.T. Wang, S. Li, X.B. Zhang, and X.P. Hou Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats Yao Xue Xue Bao 38 2003 231 235
87. M. Werle, and A.B. Schnurch Strategies to improve plasma half-life time of peptide and protein drugs Amino Acids 30 2006 351 367 (Pubitemid 43886897)
88. K.J. Widder, R.M. Morris, G.A. Poore, D.P. Howard, and A.E. Senyei Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats Eur. J. Cancer Clin. Oncol. 19 1983 135 139 (Pubitemid 13138726)
89. K.J. Widder, and A.E. Senyei Magnetic microspheres: a vehicle for selective targeting of drugs Pharmacol. Ther. 20 1983 377 395 (Pubitemid 13067756)
90. Y. Xie, M.D. Kaminski, M.D. Tornoa, M.R. Finck, X. Liu, and A.J. Rosengart Physicochemical characteristics of magnetic microspheres containing tissue plasminogen activator J. Magn. Magn. Mater. 311 2007 376 378 (Pubitemid 46400996)
91. T. Yamaoka, Y. Tabata, and Y. Ikada Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice J. Pharm. Sci. 83 1994 601 606 (Pubitemid 24222392)
92. Y. Yurko, V. Maximov, E. Andreozzi, G.L. Thompson, and A.A. Vertegel Design of biomedical nanodevices for dissolution of blood clots Mater. Sci. Eng. C 29 2009 737 741
93. S. Zaitsev, K. Danielyan, J.C. Murciano, K. Ganguly, T. Krasik, R.P. Taylor, S. Pincus, S. Jones, D.B. Cines, and V.R. Muzykantov Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis Blood 108 2006 1895 1902 (Pubitemid 44403687)